BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morita M, Taguchi K, Kagawa M, Nakanoko T, Uehara H, Sugiyama M, Ota M, Ikebe M, Sugimachi K, Esaki T, Toh Y. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract. Int J Clin Oncol. 2020;25:842-850. [PMID: 32036480 DOI: 10.1007/s10147-020-01631-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Hu H, Zheng Z, Yang Y, Chen W, Qiao X, Li P, Zhang S. Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: A population-based study. Cancer Med 2022. [PMID: 35596661 DOI: 10.1002/cam4.4829] [Reference Citation Analysis]
2 Tang N, Feng Z. Endoscopic submucosal dissection combined with adjuvant chemotherapy for early-stage neuroendocrine carcinoma of the esophagus: A case report. World J Clin Cases 2022; 10(10): 3164-3169 [DOI: 10.12998/wjcc.v10.i10.3164] [Reference Citation Analysis]
3 Gao S, Li X, Shi W, Huo L, Liu H, Zhong WL. Efficacy of the Low Dose Apatinib plus Chemotherapy on Advanced Gastric Carcinoma. Journal of Oncology 2022;2022:1-5. [DOI: 10.1155/2022/3009494] [Reference Citation Analysis]
4 Chen G, Xu Q, Qian S, Wang Z, Wang S. Survival Analysis in Gastrointestinal Neuroendocrine Carcinoma With Bone Metastasis at Diagnosis. Front Surg 2022;9:820725. [DOI: 10.3389/fsurg.2022.820725] [Reference Citation Analysis]
5 Wang MM, Singh SK. Rapidly Extensive Recurrence of Esophageal Neuroendocrine Carcinoma After Complete Pathologic Response to Definitive Chemoradiation. ACG Case Rep J 2022;9:e00730. [DOI: 10.14309/crj.0000000000000730] [Reference Citation Analysis]
6 Sato H, Saito T, Horii H, Kajiura M, Kikuchi N, Takada N, Taguchi K, Yoshida M, Hasegawa M, Taguchi H, Yoshida Y, Ando K, Fujiya M, Omori Y, Hank T, Liss AS, Gala MK, Makita Y, Ono Y, Mizukami Y, Okumura T. Case Report: A Rare Case of Esophagogastric Junctional Squamous Cell Carcinoma After the Successful Treatment of Neuroendocrine Carcinoma: Clonal Tumor Evolution Revealed by Genetic Analysis. Front Genet 2021;12:608324. [PMID: 34616420 DOI: 10.3389/fgene.2021.608324] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Han D, Li YL, Zhou ZW, Yin F, Chen J, Liu F, Shi YF, Wang W, Zhang Y, Yu XJ, Xu JM, Yang RX, Tian C, Luo J, Tan HY. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms. World J Gastroenterol 2021; 27(21): 2895-2909 [PMID: 34135560 DOI: 10.3748/wjg.v27.i21.2895] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jepsen DNM, Fiehn AK, Garbyal RS, Engel U, Holm J, Federspiel B. Immunohistochemical Staining With Neuroendocrine Markers is Essential in the Diagnosis of Neuroendocrine Neoplasms of the Esophagogastric Junction. Appl Immunohistochem Mol Morphol 2021;29:454-61. [PMID: 33480601 DOI: 10.1097/PAI.0000000000000906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]